Mechanism of Action of Mounjaro (Tirzepatide)
Introduction Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for obesity, is a dual GIP/GLP‑1 receptor agonist. This innovative “twincretin” enhances insulin secretion, suppresses glucagon, delays gastric emptying, and promotes satiety. It offers significant HbA₁c reduction and weight loss advantages over GLP‑1 agonists alone. Step-by-Step Mechanism of Action Pharmacokinetic Parameters Parameter Value Route … Read more